96226 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
Sub-classes:HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS
#2Heterocyclic compounds for the treatment of neurological and psychological disorders
#3Polymerizable compound, compound, and method for producing boranophosphate oligomer
#4CD73 inhibitors
#5Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex
#6Heterocyclic compounds for the treatment of neurological and psychological disorders
#7CD73 inhibitors
#8Morpholino oligonucleotide manufacturing method
#9Salt of quinazoline derivative, preparation method therefor and application thereof
#10Heterocyclic compounds for the treatment of neurological and psychological disorders
#11Polymerizable compound, compound, and method for producing boranophosphate oligomer
#12Fosaprepitant phosphate intermediate and preparation method therefor
#13Heterocyclic compounds for the treatment of neurological and psychological disorders
#14Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
#15Heterocyclic compounds for the treatment of neurological and psychological disorders
#16Preparation method for antitumor drug AP26113
#17Pharmaceutical dosage form for immediate release of an indolinone derivative
#18Morpholino oligonucleotide manufacturing method
#19Heterocyclic compounds for the treatment of neurological and psychological disorders
#20Multimeric dual-modality breast cancer diagnostic agents
#21Multimeric dual-modality breast cancer diagnostic agents
#22Heterocyclic compounds for the treatment of neurological and psychological disorders
#23Heterocyclic compounds for the treatment of neurological and psychological disorders
#24Inhibitors of beta-lactamase
#25Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
#26Five-membered heterocyclic compounds